Semarang is the capital and largest city of Central Java province in Indonesia. It was a major port during the Dutch colonial era, and is still an important regional center and port today.

During the past decade, Universitas Negeri Semarang conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitas Negeri Semarang" #1 collaborator was "Ministry of Research, Technology and Higher Education, Republic of Indonesia" with 2 trials as a collaborator and "Universitas Diponegoro" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitas Negeri Semarang" are "Oxidative Stress" (2 trials), "Exertion; Excess" (1 trials), "Heart Arrest" (1 trials), "Inflammatory Response" (1 trials) and "Sport Injury" (1 trials). Many other conditions were trialed in "Universitas Negeri Semarang" in a lesser frequency.

Most popular intervention types in "Universitas Negeri Semarang" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "140kms cycling" (1 trials), "Garcinia-mangostana-L-rind and Solanum-Lycopersicum-Fructus mixture-extract" (1 trials) and "Placebo Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitas Negeri Semarang" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Universitas Negeri Semarang". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitas Negeri Semarang, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitas Negeri Semarang, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".